MedTrace Logo

Efficacy and Safety of TongBi Capsule in Patients With Knee Osteoarthritis

NCT03418155 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-02-01

No results posted yet for this study

Summary

This study evaluates the efficacy and safety of TongBi capsule compared with placebo in the treatment of knee osteoarthritis in adults.Half of participants will receive TongBi capsule in combination,while the other half will receive a Placebo.

Conditions

Interventions

DRUG

Treatment of TongBi Capsule

TongBi Capsule:0.31g,3times a day, oral, for 4 weeks.

DRUG

Treatment of TongBi placebo

TongBi placebo:0.31g,3times a day, oral, for 4 weeks.

Sponsors & Collaborators

  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Jiang Quan · Guang'anmen Hospital of China Academy of Chinese Medical Sc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2019-04-01
Completion
2019-10-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03418155 on ClinicalTrials.gov